Time-to-furosemide treatment and mortality in patients hospitalized with acute heart failure Y Matsue, K Damman, AA Voors, N Kagiyama, T Yamaguchi, S Kuroda, ... Journal of the American College of Cardiology 69 (25), 3042-3051, 2017 | 335 | 2017 |
CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic Y Matsumura, JR Johnson, M Yamamoto, M Nagao, M Tanaka, ... Journal of Antimicrobial Chemotherapy 70 (6), 1639-1649, 2015 | 139 | 2015 |
Reversible ventricular dysfunction takotsubo cardiomyopathy YJ Akashi, H Musha, K Kida, K Itoh, K Inoue, K Kawasaki, N Hashimoto, ... European Journal of Heart Failure 7 (7), 1171-1176, 2005 | 137 | 2005 |
Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment―Results From the K-STAR Study― T Inomata, Y Ikeda, K Kida, Y Shibagaki, N Sato, Y Kumagai, ... Circulation Journal 82 (1), 159-167, 2017 | 70 | 2017 |
Effect of optimizing guideline-directed medical therapy before discharge on mortality and heart failure readmission in patients hospitalized with heart failure with reduced … T Yamaguchi, T Kitai, T Miyamoto, N Kagiyama, T Okumura, K Kida, ... The American journal of cardiology 121 (8), 969-974, 2018 | 58 | 2018 |
Effects of ACE2 inhibition in the post-myocardial infarction heart MA Kim, D Yang, K Kida, N Molotkova, SJ Yeo, N Varki, M Iwata, ... Journal of cardiac failure 16 (9), 777-785, 2010 | 55 | 2010 |
Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry T Nabeta, T Kitai, Y Naruse, T Taniguchi, K Yoshioka, H Tanaka, ... European Heart Journal 43 (36), 3450-3459, 2022 | 46 | 2022 |
The exercise training effects of skeletal muscle strength and muscle volume to improve functional capacity in patients with myocardial infarction K Kida, N Osada, YJ Akashi, H Sekizuka, K Omiya, F Miyake International journal of cardiology 129 (2), 180-186, 2008 | 44 | 2008 |
Reversible ventricular dysfunction (takotsubo cardiomyopathy) following polymorphic ventricular tachycardia. YJ Akashi, K Nakazawa, K Kida, S Ryu, A Takagi, R Kishi, T Kunishima, ... The Canadian journal of cardiology 19 (4), 449-451, 2003 | 43 | 2003 |
Clinical and prognostic values of ALBI score in patients with acute heart failure Y Matsue, N Kagiyama, T Yamaguchi, S Kuroda, T Okumura, K Kida, ... Heart, Lung and Circulation 29 (9), 1328-1337, 2020 | 42 | 2020 |
Diurnal blood pressure variation in patients with sleep apnea syndrome K Nagata, N Osada, M Shimazaki, K Kida, K Yoneyama, A Tsuchiya, ... Hypertension Research 31 (2), 185-191, 2008 | 38 | 2008 |
Relationship between sleep apnea syndrome and sleep blood pressure in patients without hypertension H Sekizuka, K Kida, YJ Akashi, K Yoneyama, N Osada, K Omiya, ... Journal of cardiology 55 (1), 92-98, 2010 | 37 | 2010 |
Influence of exercise-induced pulmonary hypertension on exercise capacity in asymptomatic degenerative mitral regurgitation K Suzuki, M Izumo, K Yoneyama, K Mizukoshi, R Kamijima, S Kou, ... Journal of Cardiology 66 (3), 246-252, 2015 | 34 | 2015 |
Prognostic value of BNP reduction during hospitalization in patients with acute heart failure N Kagiyama, T Kitai, A Hayashida, T Yamaguchi, T Okumura, K Kida, ... Journal of cardiac failure 25 (9), 712-721, 2019 | 32 | 2019 |
Palliative care in patients with advanced heart failure K Kida, S Doi, N Suzuki Heart failure clinics 16 (2), 243-254, 2020 | 31 | 2020 |
Influence of gender and types of sports training on QT variables in young elite athletes K Omiya, H Sekizuka, K Kida, K Suzuki, YJ Akashi, H Ohba, H Musha European journal of sport science 14, S32-S38, 2014 | 30 | 2014 |
Respiratory muscle strength in relation to sarcopenia in elderly cardiac patients KP Izawa, S Watanabe, K Oka, Y Kasahara, Y Morio, K Hiraki, Y Hirano, ... Aging clinical and experimental research 28, 1143-1148, 2016 | 29 | 2016 |
Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study K Kida, Y Shibagaki, N Tominaga, N Matsumoto, YJ Akashi, F Miyake, ... Clinical pharmacokinetics 54, 273-284, 2015 | 29 | 2015 |
Coronavirus Disease 2019 (COVID-19) Information for Cardiologists―Systematic Literature Review and Additional Analysis― T Sugimoto, A Mizuno, T Kishi, N Ito, C Matsumoto, M Fukuda, ... Circulation Journal 84 (6), 1039-1043, 2020 | 28 | 2020 |
The relation between Geriatric Nutritional Risk Index and muscle mass, muscle strength, and exercise capacity in chronic heart failure patients KP Izawa, S Watanabe, Y Hirano, S Yamamoto, K Oka, N Suzuki, K Kida, ... International journal of cardiology 177 (3), 1140-1141, 2014 | 27 | 2014 |